Cargando…

Crosstalk between ERK, AKT, and cell survival

It is historically well known that signaling by the PI3K-AKT and MEK1/2-ERK1/2 pathways in a cell type-dependent fashion can collaborate to maintain cell viability.(1)(-)(3) Signaling pathways can also crosstalk with each other wherein one pathway can signal to either enhance or suppress signaling b...

Descripción completa

Detalles Bibliográficos
Autor principal: Dent, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974823/
https://www.ncbi.nlm.nih.gov/pubmed/24424114
http://dx.doi.org/10.4161/cbt.27541
_version_ 1782310055317602304
author Dent, Paul
author_facet Dent, Paul
author_sort Dent, Paul
collection PubMed
description It is historically well known that signaling by the PI3K-AKT and MEK1/2-ERK1/2 pathways in a cell type-dependent fashion can collaborate to maintain cell viability.(1)(-)(3) Signaling pathways can also crosstalk with each other wherein one pathway can signal to either enhance or suppress signaling by another.(4) Signaling by the ERK1/2 pathway can also stimulate release of growth factors which can feed back onto tumor cells to re-energize signaling pathways.(5) The studies described by Toulany et al. add to this knowledge base by examining the relationship between PI3K-AKT and MEK1/2-ERK1/2 pathway signaling, EGF receptor signaling, K-RAS function, and tumor cell survival.(6)
format Online
Article
Text
id pubmed-3974823
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-39748232014-04-07 Crosstalk between ERK, AKT, and cell survival Dent, Paul Cancer Biol Ther Commentary It is historically well known that signaling by the PI3K-AKT and MEK1/2-ERK1/2 pathways in a cell type-dependent fashion can collaborate to maintain cell viability.(1)(-)(3) Signaling pathways can also crosstalk with each other wherein one pathway can signal to either enhance or suppress signaling by another.(4) Signaling by the ERK1/2 pathway can also stimulate release of growth factors which can feed back onto tumor cells to re-energize signaling pathways.(5) The studies described by Toulany et al. add to this knowledge base by examining the relationship between PI3K-AKT and MEK1/2-ERK1/2 pathway signaling, EGF receptor signaling, K-RAS function, and tumor cell survival.(6) Landes Bioscience 2014-03-01 2014-01-14 /pmc/articles/PMC3974823/ /pubmed/24424114 http://dx.doi.org/10.4161/cbt.27541 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Commentary
Dent, Paul
Crosstalk between ERK, AKT, and cell survival
title Crosstalk between ERK, AKT, and cell survival
title_full Crosstalk between ERK, AKT, and cell survival
title_fullStr Crosstalk between ERK, AKT, and cell survival
title_full_unstemmed Crosstalk between ERK, AKT, and cell survival
title_short Crosstalk between ERK, AKT, and cell survival
title_sort crosstalk between erk, akt, and cell survival
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974823/
https://www.ncbi.nlm.nih.gov/pubmed/24424114
http://dx.doi.org/10.4161/cbt.27541
work_keys_str_mv AT dentpaul crosstalkbetweenerkaktandcellsurvival